Article

Severe acute respiratory syndrome coronavirus 2 breakthrough infections in healthcare workers vaccinees with BNT162b2 (Pfizer-BioNtech) in Bogotá, Colombia

2022-06-01

Abstract excerpt

The healthcare workers are considered as a high-risk group for infection with SARS-CoV-2, so they were included in the first stage of the National Plan for Vaccination against COVID-19 in Colombia. An ongoing prospective cohort study to evaluate immune response to vaccination included 490 workers from health institutions in Bogotá, Colombia, vaccinated between March and June 2021 with BNT162b2 (Pfizer-BioNtech). M...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 377e63c1-0883-599a-bd70-ec46f4e6a876
DOI: 10.1101/2022.05.31.22274501

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Severe acute respiratory syndrome coronavirus 2 breakthrough infections in healthcare workers vaccinees with BNT162b2 (Pfizer-BioNtech) in Bogotá, ColombiaDOI 10.1101/2022.05.31.22274501Read

SARS-CoV-2 Vaccinated Breakthrough Infections With Fatal and Critical Outcomes in the Department of Antioquia, ColombiaSemantic proximity Read

Clinical Characteristics of Healthcare Workers with SARS-CoV-2 Infection after Vaccination with BNT162b2 VaccineSemantic proximity Read

Real-world monitoring of BNT162b2 vaccine-induced SARS-CoV-2 B and T cell immunity in naive healthcare workers: a prospective single center studySemantic proximity Read

Neutralizing responses in fully vaccinated with BNT162b2, CoronaVac, ChAdOx1, and Ad26.COV2.S against SARS-CoV-2 lineages in Colombia, 2020-2021Semantic proximity Read

Post-vaccination SARS-COV-2 among healthcare workers in New Jersey: a genomic epidemiological studySemantic proximity Read

BNT162B2 mRNA Covid-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection and Symptomatic Disease in the Medium - to Long-Term: A Retrospective Cohort StudySemantic proximity Read

Virological and Serological Characterization of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 VaccinationSemantic proximity Read

Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adultsSemantic proximity Read

Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workersSemantic proximity Read

Genomic surveillance of SARS-CoV-2 in COVID-19 vaccinated healthcare workers in LebanonSemantic proximity Read

SARS-CoV-2 Breakthrough Infections in Fully Vaccinated IndividualsSemantic proximity Read

SARS-CoV-2-Specific Immune Responses in Vaccination and Infection during the Pandemic in 2020–2022Semantic proximity Read